Breakthrough ALS study launches as drug aims to slow disease progression
✨ AI Summary
🔊 جاري الاستماع
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
